Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The yellow fever 17D virus as a platform for new live attenuated vaccines

19 Feb 2014

Abstract excerpt

The live-attenuated yellow fever 17D virus is one of the most outstanding human vaccines ever developed. It induces efficacious immune responses at a low production cost with a well-established manufacture process. These advantages make the YF17D virus attractive as a vector for the development of new vaccines. At the beginning of vector development studies, YF17D was genetically manipulated to express other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Research and Treatment
Share to Invertebrate Immune Response Mechanisms
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24553128
DOI: 10.4161/hv.28117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The yellow fever 17D virus as a platform for new live attenuated vaccinesPMID 24553128Read ↗

Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genesSemantic proximity Read ↗

A DNA Vaccine against Yellow Fever Virus: Development and EvaluationSemantic proximity Read ↗

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesSemantic proximity Read ↗

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal modelsSemantic proximity Read ↗

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 virusesSemantic proximity Read ↗

Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine developmentSemantic proximity Read ↗

Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.Semantic proximity Read ↗

Two mutations in NS2B are responsible for attenuation of the yellow fever virus (YFV) vaccine strain 17D.Semantic proximity Read ↗

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differencesSemantic proximity Read ↗

Mutation in a 17D-204 Vaccine Substrain-Specific Envelope Protein Epitope Alters the Pathogenesis of Yellow Fever Virus in MiceSemantic proximity Read ↗

E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate VirulenceSemantic proximity Read ↗

Molecular characterization of the 17D-204 yellow fever vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.